Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway
Back to article page
Original Article|Updated:2023-11-23
|
Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway
Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway
中国结合医学杂志(英文版)2023年29卷第11期 页码:998-1006
Affiliations:
1.Department of Pharmacy, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang (50001), China
2.Department of Chinese Medicine Rehabilitation, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang (50001), China
3.College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang (550025), China
4.College of Life and Health, Dalian University, Dalian, Liaoning Province (116622), China
Author bio:
Prof. LI Ling, E-mail: 1654226588@qq.com
Funds:
the National Natural Science Foundation of China(82060830);Guizhou Province Traditional Chinese Medicine, Ethnic Medicine Science, and Technology Research Poject(QZYY-2021-113);Science and Technology Fund Project of Guizhou Provincial Health Commission(gzwkj2021-457)
Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway[J]. 中国结合医学杂志(英文版), 2023,29(11):998-1006.
ZHANG Ning, YE Tao, LU Xu, et al. Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2023,29(11):998-1006.
Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway[J]. 中国结合医学杂志(英文版), 2023,29(11):998-1006. DOI: 10.1007/s11655-023-3744-7.
ZHANG Ning, YE Tao, LU Xu, et al. Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2023,29(11):998-1006. DOI: 10.1007/s11655-023-3744-7.
Radix Scrophulariae Extracts Exert Effect on Hyperthyroidism via MST1/Hippo Signaling Pathway
LC3-Ⅱ/Ⅰ) 、重组人自噬相关蛋白5 (recombinant human autophagy related
ATG5) 的表达. 采用酶联免疫吸附法检测甲状腺素 (Thyroxine
T4) 水平.
结果:
2
与空白组相比
模型组大鼠甲状腺体积明显增大 (
P
<
0.01)
出现滤泡上皮细胞大小不等、排列紊乱、形态不规则等病理变化. 高尔基体分泌小泡生成减少
受体蛋白TSH-R、T4表达显著上升 (
P
<
0.01)
MST1、p-LATS1、p-YAP、Caspase-3、LC3-Ⅱ/Ⅰ、ATG5表达显著降低 (
P
<
0.01) . Bcl-2、PCNA和cyclin D1表达显著上升 (
P
<
0.01) . 与模型组比较
玄参组甲状腺体积减小
改善了甲状腺病理状态
促进了甲状腺高尔基体内分泌双层膜结构的分泌小泡
显著抑制TSH-R和T4水平 (
P
<
0.01)
上调MST1、p-LATS1、p-YAP、Caspase-3、LC3-Ⅱ/Ⅰ和ATG5表达 (
P
<
0.01)
下调Bcl-2、PCNA
和Cyclin D1表达 (
P
<
0.01) . XMU-MP-1抑制了玄参提取物的干预作用.
结论:
2
玄参提取物能通过调节MST1/Hippo信号通路
抑制甲状腺组织增殖、促进甲状腺组织凋亡和自噬
从而达到治疗甲亢的效果.
Abstract
Objective:
2
To explore the mechanism of
Radix Scrophulariae
(RS) extracts in the treatment of hyperthyroidism rats by regulating proliferation
apoptosis
and autophagy of thyroid cell through the mammalian sterile 20-like kinase 1 (MST1)/Hippo pathway.
Methods:
2
Twenty-four rats were randomly divided into 4 groups according to a random number table: control
model group
RS
and RS+Hippo inhibitor (XMU-MP-1) groups (
n
= 6 per group). Rats were gavaged with levothyroxine sodium tablet suspension (LST
8 μg/kg) for 21 days except for the control group. Afterwards
rats in the RS group were gavaged with RS extracts at the dose of 1
350 mg/kg
and rats in the RS+XMU-MP-1 group were gavaged with 1
350 mg/kg RS extracts and 1 mg/kg XMU-MP-1. After 15 days of administration
thyroid gland was taken for gross observation
and histopathological changes were observed by hematoxylin-eosin staining. The structure of Golgi secretory vesicles in thyroid tissues was observed by transmission electron microscopy. The expression of thyrotropin receptor (TSH-R) was observed by immunohistochemistry. Terminal-deoxynucleoitidyl transferase mediated nick end labeling assay was used to detect cell apoptosis in thyroid tissues. Real-time quantity primer chain reaction and Western blot were used to detect the expressions of MST1
and recombinant human autophagy related 5 (ATG5). Thyroxine (T4) level was detected by enzyme-linked immunosorbent assay.
Results:
2
The thyroid volume of rats in the model group was significantly increased compared to the normal control group (
P
<
0.01)
and pathological changes such as uneven size of follicular epithelial cells
disorderly arrangement
and irregular morphology occurred. The secretion of small vesicles by Golgi apparatus was reduced
and the expressions of receptor protein TSH-R and T4 were significantly increased (
P
<
0.01)
while the expressions of MST1
p-LATS1
p-YAP
Caspase-3
LC3-Ⅱ/Ⅰ
and ATG5 were significantly decreased (
P
<
0.01). The expressions of Bcl-2
PCNA
and cyclin D1 were significantly increased (
P
<
0.01). Compared with the model group
RS extracts reduced the volume of thyroid gland
improved pathological condition of the thyroid gland
promoted secretion of the secretory vesicles with double-layer membrane structure in thyroid Golgi
significantly inhibited the expression of TSH-R and T4 levels (
P
<
0.01)
upregulated MST1
p-LATS1
p-YAP
Caspase-3
LC3-Ⅱ/Ⅰ
and ATG5 expressions (
P
<
0.01)
and downregulated Bcl-2
PCNA
and Cyclin D1 expressions (
P
<
0.01). XMU-MP-1 inhibited the intervention effects of RS extracts (
P
<
0.01).
Conclusion:
2
RS extracts could inhibit proliferation and promote apoptosis and autophagy in thyroid tissues through MST1/Hippo pathway for treating hyperthyroidism.
关键词
玄参提取物左甲状腺素钠片甲亢MST1/Hippo信号通路增殖凋亡自噬
Keywords
Radix Scrophulariae extractslevothyroxine sodium tabletshyperthyroidismMST1/Hippo signal pathwayproliferationapoptosisautophagy